These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9687175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative Study of Pharmacopoeias in Japan, Europe, and the United States: Toward the Further Convergence of International Pharmacopoeial Standards.
    Kameyama Y, Matsuhama M, Mizumaru C, Saito R, Ando T, Miyazaki S.
    Chem Pharm Bull (Tokyo); 2019; 67(12):1301-1313. PubMed ID: 31787657
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. International specification setting--EP perspectives. European Pharmacopoeia.
    Calam DH.
    Dev Biol (Basel); 2002; 107():129-34. PubMed ID: 12079187
    [Abstract] [Full Text] [Related]

  • 7. [ICH4 and pharmacopoeias: similarities and differences].
    Artiges A.
    Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473
    [Abstract] [Full Text] [Related]

  • 8. The role of pharmacopoeias in international harmonisation.
    Artiges A.
    J Pharm Biomed Anal; 2001 Mar; 24(5-6):769-72. PubMed ID: 11248469
    [Abstract] [Full Text] [Related]

  • 9. [Certification of suitability of monographs of the European pharmacopoeia].
    Artiges A.
    Ann Pharm Fr; 2002 Sep; 60(5):333-40. PubMed ID: 12378143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect Analysis.
    Matsuhama M, Saito R, Miyazaki S.
    Chem Pharm Bull (Tokyo); 2020 Sep; 68(11):1034-1048. PubMed ID: 33132370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.